If you’re pregnant at 35 or older, you’ve probably heard the term NIPT come up — whether from your OB-GYN, midwife, or a well-meaning search engine. Non-invasive prenatal testing has become one of the most discussed prenatal screening options for women of advanced maternal age, and for good reason. But what does it actually involve, what can it tell you, and what are its limits? This article takes a clear, evidence-based look at what the research shows.
What the Research Says About NIPT and Age
The likelihood of certain chromosomal differences in a pregnancy increases with maternal age. According to the American College of Obstetricians and Gynecologists (ACOG), the risk of fetal aneuploidy — where a baby has an atypical number of chromosomes — rises gradually throughout the reproductive years and more steeply after 35. This is why prenatal screening is routinely discussed with patients in this age group.
NIPT, sometimes called cell-free DNA screening (cfDNA), analyses fragments of fetal DNA circulating in the pregnant person’s bloodstream. A 2020 review in the New England Journal of Medicine found that NIPT has a detection rate exceeding 99% for trisomy 21 (Down syndrome), with a false-positive rate of less than 0.1%. These figures have made it one of the most accurate screening tools currently available — though it remains a screening test, not a diagnostic one.
What NIPT Screens For
Standard NIPT panels typically screen for the three most common autosomal trisomies, though different providers offer different panel options. Understanding what is and isn’t included in your test is an important part of informed decision-making.
The Three Main Trisomies
Trisomy 21, or Down syndrome, is the most common chromosomal condition screened for via NIPT. It occurs when there are three copies of chromosome 21 instead of two. Trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) are also included in most standard panels. Both are associated with more severe developmental differences and, sadly, are often incompatible with life beyond early infancy.
Sex Chromosome Conditions
Many NIPT panels also screen for sex chromosome aneuploidies, such as monosomy X (Turner syndrome), XXX (Trisomy X), XXY (Klinefelter syndrome), and XYY syndrome. Detection accuracy for these conditions is generally lower than for the autosomal trisomies, and false-positive rates are higher. Some people choose to opt out of this portion of the panel, and that’s a perfectly reasonable decision to make in consultation with your provider.
Microdeletions and Expanded Panels
Some providers offer expanded NIPT panels that screen for microdeletion syndromes — small missing segments of chromosomes associated with conditions like DiGeorge syndrome or Prader-Willi syndrome. The evidence base for microdeletion screening via cfDNA is less robust than for the common trisomies. ACOG and the Society for Maternal-Fetal Medicine (SMFM) note that expanded panels come with higher rates of false positives and uncertain variants, and they recommend patients be offered genetic counselling before and after these tests.
Screening vs. Diagnostic: A Crucial Distinction
One of the most important things to understand about NIPT — and one that sometimes gets lost in the initial conversation — is that it is a screening test, not a diagnostic one. A positive NIPT result does not confirm a diagnosis. It identifies a higher probability that a chromosomal difference is present, which then typically leads to a discussion about diagnostic testing.
Diagnostic tests, such as chorionic villus sampling (CVS) or amniocentesis, involve sampling fetal cells directly and can definitively confirm or rule out chromosomal conditions. These procedures do carry a small risk of pregnancy loss — typically cited at around 0.5–1% — which is one reason why screening tests like NIPT are often used as a first step.
It’s also worth noting that a negative NIPT result does not guarantee an unaffected pregnancy. NIPT screens for specific conditions, not all possible chromosomal or genetic differences. Your healthcare provider can help you understand what a result means in the context of your full clinical picture.
When NIPT Is Typically Offered
NIPT can generally be performed from around 10 weeks of pregnancy, which is earlier than some other prenatal screening methods. This early window is one reason it has become increasingly popular — results are usually available within one to two weeks of the blood draw, giving patients more time to consider their options if a result comes back with elevated risk.
In many healthcare systems, NIPT is offered to all pregnant people, though in some it may be specifically recommended for those considered at higher risk, including those of advanced maternal age. Coverage and availability vary depending on where you live and your insurance or healthcare plan. It’s worth asking your provider directly about local protocols and any associated costs.
Understanding NIPT Accuracy After 35
Performance of NIPT varies depending on factors including gestational age, fetal fraction (the proportion of cell-free DNA that comes from the placenta), maternal weight, and the specific condition being screened for. Generally speaking, higher-risk populations — such as those 35 and older — tend to have higher positive predictive values (PPV) from NIPT, because prevalence of the target conditions is higher.
What this means in practical terms: a positive NIPT result in a 38-year-old is more likely to be a true positive than the same result in a 25-year-old, because the underlying prevalence differs. Even so, ACOG emphasises that all patients receiving a positive NIPT result should be offered confirmatory diagnostic testing before any irreversible decisions are made.
The Emotional Dimension of Prenatal Screening
Deciding whether to undergo prenatal screening — and how to respond to results — is deeply personal. Some people find NIPT reassuring; a low-risk result can reduce anxiety during a pregnancy that already carries heightened monitoring. Others find that the process of screening raises concerns they hadn’t anticipated, or that waiting for results adds stress rather than reducing it.
There is no universally correct approach. Some people decline all prenatal screening because knowing earlier wouldn’t change the course of their pregnancy; others want as much information as possible to prepare emotionally, practically, or medically. What matters most is that you feel informed about what the test can and cannot tell you, and that you make a decision that aligns with your values and circumstances.
If you’re finding the decision-making process around prenatal testing emotionally overwhelming, speaking with a genetic counsellor can be incredibly helpful. They are trained to present the data in context, help you understand what different scenarios might look like, and support you through the decision process without pressure in either direction.
Frequently Asked Questions
Is NIPT recommended for all pregnancies after 35?
ACOG recommends that all pregnant people — regardless of age — be offered prenatal screening or diagnostic testing. For those 35 and over, NIPT is often specifically discussed given the increased prevalence of chromosomal differences in this group. Whether to proceed is an individual decision made in consultation with your care team.
Can NIPT tell me my baby’s sex?
Yes, as part of screening for sex chromosome conditions, NIPT can identify fetal sex. If you’d prefer not to know, you can ask your provider or lab to withhold that information from your report. Not all providers automatically share this, so it’s worth discussing your preferences in advance.
What happens if NIPT comes back high risk?
A high-risk NIPT result does not mean a diagnosis has been confirmed. Your provider will typically recommend referral to a maternal-fetal medicine specialist and a genetic counsellor. Diagnostic testing such as CVS or amniocentesis may be offered. Taking time to gather more information before making any decisions is entirely appropriate and supported by clinical guidelines.
Is NIPT covered by insurance?
Coverage varies widely. In the US, many insurers cover NIPT for high-risk pregnancies, which typically includes maternal age 35 or older, but coverage for average-risk pregnancies is inconsistent. It’s worth checking with your insurance provider before scheduling the test. In some countries, NIPT is available through public healthcare systems for high-risk patients.
How soon after NIPT can I expect results?
Most NIPT results are returned within seven to fourteen days of the blood draw, though turnaround times vary by lab. Some labs offer expedited processing. Your provider’s office will typically contact you when results are available and guide you through what they mean.
Key Takeaways
- NIPT is a blood-based screening test that analyses cell-free fetal DNA, with high accuracy for detecting common chromosomal trisomies.
- It is a screening tool, not a diagnostic one — a positive result requires follow-up with confirmatory testing before any conclusions are drawn.
- Women 35 and older tend to have higher positive predictive values from NIPT due to increased underlying prevalence of the screened conditions.
- Deciding whether to have NIPT is personal — there is no medically required answer, and genetic counselling is a valuable resource when making this decision.
- Results typically take one to two weeks, and high-risk results should be discussed with a specialist before any irreversible decisions are made.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding your individual circumstances, screening options, and test results.
About the Author: Emily Carter is a women’s health writer and researcher with a focus on reproductive health, fertility, and the physiological changes that accompany ageing. Her work draws on peer-reviewed research to provide evidence-based insights for women navigating health decisions at every stage of life.